BIOMAT Database Logo BIOMAT Database Logo

Effects of the oral converting enzyme inhibitor (SQ 14225) on one-kidney hypertension in the dog. 1978

B E Watkins, and J O Davis, and R H Freeman, and G A Stephens, and J M DeForrest

UI MeSH Term Description Entries
D006977 Hypertension, Renal Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN. Hypertensions, Renal,Renal Hypertension,Renal Hypertensions
D009392 Nephrectomy Excision of kidney. Heminephrectomy,Heminephrectomies,Nephrectomies
D011392 Proline A non-essential amino acid that is synthesized from GLUTAMIC ACID. It is an essential component of COLLAGEN and is important for proper functioning of joints and tendons. L-Proline,L Proline
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D001920 Bradykinin A nonapeptide messenger that is enzymatically produced from KALLIDIN in the blood where it is a potent but short-lived agent of arteriolar dilation and increased capillary permeability. Bradykinin is also released from MAST CELLS during asthma attacks, from gut walls as a gastrointestinal vasodilator, from damaged tissues as a pain signal, and may be a neurotransmitter. Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg,Bradykinin Acetate, (9-D-Arg)-Isomer,Bradykinin Diacetate,Bradykinin Hydrochloride,Bradykinin Triacetate,Bradykinin, (1-D-Arg)-Isomer,Bradykinin, (2-D-Pro)-Isomer,Bradykinin, (2-D-Pro-3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (2-D-Pro-7-D-Pro)-Isomer,Bradykinin, (3-D-Pro)-Isomer,Bradykinin, (3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (5-D-Phe)-Isomer,Bradykinin, (5-D-Phe-8-D-Phe)-Isomer,Bradykinin, (6-D-Ser)-Isomer,Bradykinin, (7-D-Pro)-Isomer,Bradykinin, (8-D-Phe)-Isomer,Bradykinin, (9-D-Arg)-Isomer,Arg Pro Pro Gly Phe Ser Pro Phe Arg
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005260 Female Females
D000450 Aldosterone A hormone secreted by the ADRENAL CORTEX that regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium. Aldosterone, (+-)-Isomer,Aldosterone, (11 beta,17 alpha)-Isomer
D000803 Angiotensin I A decapeptide that is cleaved from precursor angiotensinogen by RENIN. Angiotensin I has limited biological activity. It is converted to angiotensin II, a potent vasoconstrictor, after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME.

Related Publications

B E Watkins, and J O Davis, and R H Freeman, and G A Stephens, and J M DeForrest
Effects of the oral converting enzyme inhibitor SQ 14225 in experimental high output failure.
June 1979, The American journal of physiology,
B E Watkins, and J O Davis, and R H Freeman, and G A Stephens, and J M DeForrest
Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in man.
May 1978, The New England journal of medicine,
B E Watkins, and J O Davis, and R H Freeman, and G A Stephens, and J M DeForrest
Effects of angiotensin I converting enzyme inhibitor (SQ 14225) on control of aldosterone.
June 1980, Acta endocrinologica,
B E Watkins, and J O Davis, and R H Freeman, and G A Stephens, and J M DeForrest
Effects of angiotensin I-converting enzyme inhibitor, SQ 14225, in nomal men.
June 1979, Endocrinologia japonica,
B E Watkins, and J O Davis, and R H Freeman, and G A Stephens, and J M DeForrest
Effects of the oral converting enzyme inhibitor, SQ 14225, in a model of low cardiac output in dogs.
October 1979, Circulation research,
B E Watkins, and J O Davis, and R H Freeman, and G A Stephens, and J M DeForrest
Haemodynamics of orally-active converting enzyme inhibitor (SQ 14225) in hypertensive patients.
November 1978, Clinical science and molecular medicine,
B E Watkins, and J O Davis, and R H Freeman, and G A Stephens, and J M DeForrest
[The effect of angiotensin I converting enzyme inhibitor (SQ 14225) on arterial blood pressure].
April 1982, Nihon Jinzo Gakkai shi,
B E Watkins, and J O Davis, and R H Freeman, and G A Stephens, and J M DeForrest
Effect of angiotensin I converting enzyme inhibitor, SQ 14225, on renin production and release.
January 1981, Nephron,
B E Watkins, and J O Davis, and R H Freeman, and G A Stephens, and J M DeForrest
Effect of the converting-enzyme inhibitor SQ 14 225 (captopril) in early one-kidney, one-clip hypertension in the rat.
April 1981, Clinical science (London, England : 1979),
B E Watkins, and J O Davis, and R H Freeman, and G A Stephens, and J M DeForrest
[Effect of angiotensin converting enzyme inhibitor (SQ 14225) on renin-angiotesin sytem and haemodynamics (author's transl)].
January 1980, Horumon to rinsho. Clinical endocrinology,
Copied contents to your clipboard!